Veracyte, Inc. (VCYT)

Veracyte Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-74.4	-36.56	-75.56	-34.91	-12.6
Depreciation & Amortization	31.35	29.25	21.23	8.91	5.15
Share-Based Compensation	33.14	26.73	22.52	13	9.81
Other Operating Activities	54.14	-11.89	0.2	3.3	-5.59
Operating Cash Flow	44.22	7.54	-31.62	-9.71	-3.23
Operating Cash Flow Growth	486.89%	-	-	-	-
Capital Expenditures	-9.96	-8.55	-5.38	-2.84	-2.73
Acquisitions	0	0	-736.83	0	-40
Change in Investments	25.07	-20.84	3	-1	0
Investing Cash Flow	15.11	-29.39	-739.21	-3.84	-42.73
Share Issuance / Repurchase	9.58	7.94	605.35	207.54	153.47
Debt Issued / Paid	0	-1.28	0	-0.1	-25.21
Other Financing Activities	-6.74	-3.17	-9.03	-3.85	-0.98
Financing Cash Flow	2.84	3.49	596.32	203.6	127.29
Exchange Rate Effect	0.16	-0.59	-1.51	0	0
Net Cash Flow	62.17	-18.36	-174.51	190.05	81.32
Free Cash Flow	34.26	-1.01	-37	-12.55	-5.97
Free Cash Flow Margin	9.49%	-0.34%	-16.85%	-10.68%	-4.96%
Free Cash Flow Per Share	0.47	-0.01	-0.55	-0.24	-0.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).